EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Machine Learning‐Guided Discovery of Novel Inhibitors of Escherichia coli MurB

Shuhua Song iD, Qingxin Liu iD, Aoqi Luo, Xiao Shi iD, Xinxin Si iD

Chemical Biology & Drug Design · 2026-11 · 108 (5)

DOI: 10.1111/cbdd.70422 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 05.11.2026. Verfasst von Shuhua Song und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Jiangsu Ocean University, Lianyungang, China. Hauptthemen laut MEDLINE: Machine Learning, Escherichia coli, Enzyme Inhibitors, Anti-Bacterial Agents. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Ocean University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MurB, a key enzyme involved in bacterial cell wall biosynthesis, represents a promising target for antibacterial drug discovery. In this study, a machine learning assay was employed to identify potential inhibitors targeting E. coli MurB. Five machine learning models were constructed using AutoMolDesigner, of which the RDKit_2D ‐ based Model_2 was selected as the optimal activity ‐ prediction model for virtual screening of an in ‐ house compound library, yielding 238 compounds. These compounds were subsequently subjected to FRED molecular docking, and 16 candidate compounds were selected based on their hydrogen ‐ bond interactions with the key active ‐ site residue ASN A:233. Preliminary enzyme inhibition assays conducted at 50 μM identified 4 compounds (Q9, Q11, Q12, and Q13) with inhibition rates exceeding 50%. Further IC₅₀ determination revealed values of 34.44, 31.45, 25.08, and 25.94 μM, respectively. Molecular dynamics simulations combined with principal component analysis were performed to investigate the dynamic behaviors and binding stability of the MurB ‐ ligand complexes. In addition, a CCK ‐ 8 assay was conducted in HepG2 cells to evaluate the cytotoxicity of the active compounds preliminarily. Collectively, 4 low ‐ cytotoxic micromolar MurB inhibitors were identified in this study, offering promising scaffolds for further mechanistic investigation and structural optimization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningEscherichia coliEnzyme InhibitorsAnti-Bacterial AgentsMolecular Docking SimulationHumansMolecular Dynamics SimulationHep G2 CellsDrug DiscoveryHydrogen BondingCatalytic DomainPrincipal Component AnalysisAlkyl and Aryl Transferases

Stichwörter der Autor:innen

MurBmachine learningmolecular dockingvirtual screening

Substanzen

Enzyme InhibitorsUDP-N-acetylglucosamine 1-carboxyvinyltransferaseAnti-Bacterial AgentsAlkyl and Aryl Transferases

Autor:innen und Institutionen

  • School of Pharmacy, Jiangsu Ocean University, Lianyungang, China.

ORCID-Profile: Shuhua Song, Qingxin Liu, Xiao Shi, Xinxin Si

Förderung

  • Jiangsu Ocean University

Zitieren

APA

Song, S., Liu, Q., Luo, A., Shi, X., & Si, X. (2026). Machine Learning‐Guided Discovery of Novel Inhibitors of Escherichia coli MurB. Chemical Biology & Drug Design, 108(5). https://doi.org/10.1111/cbdd.70422

Vancouver

Song S, Liu Q, Luo A, Shi X, Si X. Machine Learning‐Guided Discovery of Novel Inhibitors of Escherichia coli MurB. Chemical Biology & Drug Design. 2026;108(5). doi:10.1111/cbdd.70422

BibTeX
@article{Song2026,
  author = {Song, Shuhua and Liu, Qingxin and Luo, Aoqi and Shi, Xiao and Si, Xinxin},
  title = {Machine Learning‐Guided Discovery of Novel Inhibitors of Escherichia coli MurB},
  journal = {Chemical Biology & Drug Design},
  year = {2026},
  volume = {108},
  number = {5},
  doi = {10.1111/cbdd.70422}
}
Kostenlos starten →